Not exact matches
The researchers, at St. Jude Children's Research Hospital in Memphis, Tennessee, and Washington University in St. Louis in Missouri, and
led by
pediatric researcher and St. Jude's CEO James Downing, hunted for dangerous genes in 1120
cancer patients under the age of 20.
Researchers
leading the largest genomic tumor profiling effort of its kind say such studies are technically feasible in a broad population of adult and
pediatric patients with many different types of
cancer, and that some patients can benefit by receiving precision drugs targeted to their tumors» mutations or being enrolled in clinical trials.
The characterization of the genetic alterations observed in neuroblastoma
led to the identification of major players of neuroblastoma oncogenesis that has considerably improved our understanding of the biology of this
pediatric cancer.
It was this research that
led to dramatic increases in
pediatric cancer survival rates.
Overweight
pediatric cancer patients who eat a healthy diet and exercise regularly may improve outcomes and reduce treatment side effects that cause disease, according to a review study led by researchers at MD Anderson Children's Cancer Hos
cancer patients who eat a healthy diet and exercise regularly may improve outcomes and reduce treatment side effects that cause disease, according to a review study
led by researchers at MD Anderson Children's
Cancer Hos
Cancer Hospital.
Northwestern Mutual, a
leading national financial security company, supports
pediatric cancer patients and their families at UNC Lineberger by funding The Northwestern Mutual Retreat for Families with C
cancer patients and their families at UNC Lineberger by funding The Northwestern Mutual Retreat for Families with
CancerCancer.
The department's history of strength in treating
pediatric cancers also
led to a collaboration with Children's National Medical Center Hospital.
«These insights will
lead to new treatments by hindering a
cancer's ability to survive,» said John Cunningham, MD, section chief of
pediatric hematology / oncology and professor of pediatrics, physiology and stem cell research.
My studies of
cancer genomes have
led to characterization of multiple
pediatric and adult tumor types, to development of methods that identify and characterize changes in genomic heterogeneity, to defining acquired resistance mechanisms to targeted therapies and to designing novel, personalized vaccines for individual patients.
Although
pediatric cancer is rare, it's the
leading cause of disease - related death among children who survive past infancy (in the Western world).
Two consortium -
led studies published last month in the journal Nature offer the most comprehensive surveys to - date of
pediatric cancer genomes.
We are equally pleased that Peter Cole, a highly accomplished clinician and researcher, will be
leading our
Pediatric Hematology / Oncology Program and helping to expand the depth and breadth of
pediatric cancer treatment offerings across RWJBarnabas Health,» notes Rutgers Cancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for
cancer treatment offerings across RWJBarnabas Health,» notes Rutgers
Cancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for
Cancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for
cancer programs for
cancer programs for RBHS.
In 2008, she
led an international coalition of
pediatric cancer physicians and researchers who developed new systems to standardize studies of neuroblastoma worldwide.
«He rapidly built up our
pediatric cancer program by recruiting
leading faculty, establishing new programs, expanding our clinical trial and bone marrow transplantation programs, strengthening basic research efforts and working with his colleagues to build relationships with community hospitals and referring physicians,» Polonsky said.
Minneapolis, MN About Blog Love Your Melon is an apparel brand dedicated to giving a hat to every child battling
cancer in America as well as supporting nonprofit organizations who
lead the fight against
pediatric cancer.
MADISON, NJ (April 12, 2012)-- Pfizer Animal Health, an international leader in the advancement of animal health, and the American Humane Association, the nation's
leading advocate on behalf of children and animals, announced the completion of the first round of an innovative research study on the benefits of animal - assisted therapy (AAT) on
pediatric cancer patients and their families.
Minneapolis, MN About Blog Love Your Melon is an apparel brand dedicated to giving a hat to every child battling
cancer in America as well as supporting nonprofit organizations who
lead the fight against
pediatric cancer.
Minneapolis, MN About Blog Love Your Melon is an apparel brand dedicated to giving a hat to every child battling
cancer in America as well as supporting nonprofit organizations who
lead the fight against
pediatric cancer.
Minneapolis, MN About Blog Love Your Melon is an apparel brand dedicated to giving a hat to every child battling
cancer in America as well as supporting nonprofit organizations who
lead the fight against
pediatric cancer.